How long does it take to see obvious effects of Canafenib/Encofenib (Betavit)?

Canafenib/Encorafen (Encorafenib) is an oral BRAF inhibitor, mainly used to treat patients with advanced melanoma and certain advanced colorectal cancers carrying BRAF V600 mutations. The drug selectively inhibits the mutated BRAF kinase and blocks the MAPK signaling pathway, thereby inhibiting cancer cell proliferation and promoting apoptosis. Because its mechanism of action is to target mutated signaling pathways, it usually takes some time for patients to observe significant clinical effects.

Clinical studies have shown that most patients can detect signs of tumor volume reduction or lesion stabilization in imaging examinations within 4–8 weeks after starting to take Encorafenib. Early signs of efficacy may include declines in tumor markers, shrinkage of radiographic lesions, and improvement in symptoms, such as pain relief or improved quality of life. However, some patients may take longer to experience significant improvement, which is closely related to individual tumor burden, mutation type, and previous treatment history.

In terms of treatment observation, doctors usually recommend imaging review, such as CT or MRI, every 6–8 weeks to evaluate changes in tumor size and drug efficacy. At the same time, it is necessary to make a comprehensive judgment on the efficacy based on the patient's symptom improvement and hematological indicators. If the patient does not see significant effects after two to three consecutive courses of treatment, doctors may consider adjusting the dose or combining it with other targeted drugs or immunotherapy to optimize the treatment effect.

It should be noted that EncorafenibAlthough it can quickly exert its targeted effect, drug efficacy and tolerability are closely related. Patients should strictly follow the doctor's instructions while taking the medicine, and should not stop taking the medicine or adjust the dosage at will, and regularly monitor liver function, electrolytes, electrocardiogram and other indicators to detect and deal with possible adverse reactions in a timely manner. By standardizing medication and observing the course of treatment, most patients can see treatment effects within a few weeks and maintain stable condition during subsequent courses of treatment.

Reference materials:https://www.drugs.com/